ClinicalTrials HQ

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Recruiting · NCT06060613 · Registry updated 2026-10-05
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Efficacy of OBX-115 in Advanced Solid TumorsNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung cancer, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, metastatic melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasmRecruitingPhase 1 / Phase 22026-10-05NCT06060613

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Obsidian Therapeutics, Inc.1

10 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Allegheny Research Institute (Melanoma/NSCLC)PittsburghUnited States1
James Graham Brown Cancer Center (Melanoma/NSCLC)LouisvilleUnited States1
M.D. Anderson Cancer Center (Melanoma/NSCLC)HoustonUnited States1
Melanoma Institute of AustraliaWollstonecraftAustralia3
Memorial Sloan Kettering (Melanoma/NSCLC)New YorkUnited States1
Orlando Health Cancer Institute (Melanoma/NSCLC)OrlandoUnited States1
Stanford Cancer Institute (Melanoma/NSCLC)StanfordUnited States1
The Angeles Clinic and Research Institute (Melanoma)Los AngelesUnited States1
The Ohio State UniversityColumbusUnited States191
USC Norris Comprehensive Cancer Center (Melanoma/NSCLC)Los AngelesUnited States1